NDC Package 51655-012-03 Dexamethsone

View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

51655-012-03

Package Description:

3 TABLET in 1 BOTTLE, DISPENSING

Product Code:

51655-012

Proprietary Name:

Dexamethsone

Usage Information:

Allergic StatesControl of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness.Dermatologic DiseasesBullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome).Endocrine DisordersPrimary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis.Gastrointestinal DiseasesTo tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis.Hematologic DisordersAcquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults, pure red cell aplasia, and selected cases of secondary thrombocytopenia.MiscellaneousDiagnostic testing of adrenocortical hyperfunction, trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy.Neoplastic DiseasesFor the palliative management of leukemias and lymphomas.Nervous SystemAcute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury.Ophthalmic DiseasesSympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.Renal DiseasesTo induce a diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus.Respiratory DiseasesBerylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis.Rheumatic DisordersAs adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus.

11-Digit NDC Billing Format:

51655001203

NDC to RxNorm Crosswalk:

RxCUI: 197582 - dexAMETHasone 4 MG Oral Tablet

RxCUI: 197582 - dexamethasone 4 MG Oral Tablet

Labeler Name:

Northwind Pharmaceuticals, Llc

Sample Package:

Start Marketing Date:

08-11-2014

Listing Expiration Date:

12-31-2019

Exclude Flag:

Code Structure:

51655 - Northwind Pharmaceuticals, Llc
- 51655-012 - Dexamethsone
  - 51655-012-03 - 3 TABLET in 1 BOTTLE, DISPENSING

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
51655-012-87	6 TABLET in 1 BOTTLE, DISPENSING

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 51655-012-03?

The NDC Packaged Code 51655-012-03 is assigned to a package of 3 tablet in 1 bottle, dispensing of Dexamethsone, labeled by Northwind Pharmaceuticals, Llc. The product's dosage form is and is administered via form.

Is NDC 51655-012 included in the NDC Directory?

No, Dexamethsone with product code 51655-012 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Northwind Pharmaceuticals, Llc on August 11, 2014 and its listing in the NDC Directory is set to expire on December 31, 2019 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 51655-012-03?

The 11-digit format is 51655001203. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	51655-012-03	5-4-2	51655-0012-03

Table of Contents